Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WOMEN&More weekly mifepristone contraception study
NL-OMON59295Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mifepristone in contraception, sponsored by Leiden University Medical Center. Primary endpoint: Overall Pearl Index. Started Apr 2025; status: active, not recruiting.
02
Drugs
mifepristone
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON59295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59295.